Publicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (18)

2024

  1. Tubulo-interstitial inflammation increases the risk of graft loss after the recurrence of IgA nephropathy

    Clinical Kidney Journal, Vol. 17, Núm. 1

2023

  1. Lymphoproliferative disorders after renal transplantation along 2 decades: A large longitudinal study of 21,546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

  2. Lymphoproliferative disorders after renal transplantation along 2 decades: a large longitudinal study of 21.546 recipients

    Nefrologia, Vol. 43, Núm. 4, pp. 427-434

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

2021

  1. Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study

    Clinical Transplantation, Vol. 35, Núm. 5

2020

  1. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study

    Clinical Transplantation, Vol. 34, Núm. 1

2019

  1. Direct-Acting Antivirals for the Treatment of Kidney Transplant Patients with Chronic Hepatitis C Virus Infection in Spain: A Long-Term Prospective Observational Study

    Transplantation Direct, Vol. 5, Núm. 12

2013

  1. A form of apolipoprotein A-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation

    American Journal of Transplantation, Vol. 13, Núm. 2, pp. 493-500

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2009

  1. Use of Mycophenolate Sodium in Stable Renal Transplant Recipients in Spain: Preliminary Results of the MIDATA Study

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2309-2312

2008

  1. Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus

    Transplantation, Vol. 86, Núm. 4, pp. 620-622

2007

  1. Early Sirolimus Use With Cyclosporine Elimination Does Not Induce Progressive Proteinuria

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2151-2152

  2. Use of the New Proliferation Signal Inhibitor Everolimus in Renal Transplant Patients in Spain: Preliminary Results of the EVERODATA Registry

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2157-2159

2006

  1. Conversión a sirolimus

    Nefrologia, Vol. 26, Núm. SUPPL.2, pp. 52-63

  2. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction

    Nephrology Dialysis Transplantation, Vol. 21, Núm. 11, pp. 3252-3257

  3. Manejo de sirolimus en la práctica clínica

    Nefrologia, Vol. 26, Núm. SUPPL.2, pp. 64-93

  4. Uso de sirolimus en el paciente «De Novo»

    Nefrologia, Vol. 26, Núm. SUPPL.2, pp. 33-51

2001

  1. Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine

    Transplantation Proceedings